Ebstine solid oral preparation and its preparing method
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- HUBEI LIYI PHARM TECH CO LTD
- Publication Date
- 2011-04-06
Smart Images
Figure 1
Abstract
Description
technical field
[0001] The present invention relates to the pharmaceutical field, more specifically to a solid oral preparation of ebastine (including orally disintegrating tablets, chewable tablets, dispersible tablets and capsules), and also to a preparation method for the solid oral preparation of ebastine. The application of ebastine solid oral preparations in the field of allergic diseases, such as urticaria, allergic rhinitis, eczema, dermatitis, prurigo, pruritus, etc. Background technique
[0002] Ebastine (EBA for short) is a new long-acting non-sedating second-generation histamine H 1 receptor antagonists. This product is mainly metabolized into carbastine (also known as caristine carebastine) in the body, which has a negative effect on histamine H 1 The receptor has a selective antagonistic effect, can inhibit the release of histamine, and has an effect on the H in the central nervous system. 1 Receptor antagonist and anticholinergic effects are weak. Preclini...